Invivyd (IVVD) Other Accumulated Expenses (2022 - 2025)

Invivyd (IVVD) posted Other Accumulated Expenses of $52000.0 for Q4 2025, up 62.5% on a QoQ basis from $32000.0 in Q3 2025, and up 92.59% year-over-year from $27000.0 in Q4 2024.

Invivyd (IVVD) Other Accumulated Expenses (2022 - 2025) Analysis & Trends

Invivyd's Other Accumulated Expenses history runs 4 years deep, the most recent figure standing at $52000.0 for Q4 2025.

  • Quarterly Other Accumulated Expenses rose 92.59% year-over-year to $52000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $52000.0 (up 92.59% YoY) and the FY2025 annual result came in at $52000.0, up 92.59% from the prior year.
  • Other Accumulated Expenses was $52000.0 for Q4 2025 at Invivyd, up from $32000.0 in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $58000.0 in Q2 2022 and bottomed at $20000.0 in Q3 2024.
  • A 4-year average of $37666.7 and a median of $35000.0 in 2023 frame the typical range for Other Accumulated Expenses.
  • Annual changes were most pronounced in 2023 — Other Accumulated Expenses sank 49.06% — and 2025, when it surged 92.59%.
  • Invivyd's Other Accumulated Expenses stood at $44000.0 in 2022, then decreased by 20.45% to $35000.0 in 2023, then declined by 22.86% to $27000.0 in 2024, then jumped by 92.59% to $52000.0 in 2025.
  • Business Quant data shows IVVD's Other Accumulated Expenses at $52000.0 in Q4 2025, $32000.0 in Q3 2025, and $26000.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Invivyd 104.07 Mn -122.62 Mn 16.07 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 52,000.00
Sep 30, 2025 32,000.00
Jun 30, 2025 26,000.00
Mar 31, 2025 34,000.00
Dec 31, 2024 27,000.00
Sep 30, 2024 20,000.00
Jun 30, 2024 21,000.00
Mar 31, 2024 40,000.00
Dec 31, 2023 35,000.00
Sep 30, 2023 27,000.00
Jun 30, 2023 38,000.00
Mar 31, 2023 58,000.00
Dec 31, 2022 44,000.00
Sep 30, 2022 53,000.00
Jun 30, 2022 58,000.00